
Rznomics' gene therapy selected for Korea's national drug development project
Rznomics said Friday that its anticancer gene therapy RZ-001 had been selected as a clinical-stage support project for this year’s first National New Drug Development Project under the auspices of the Korea Drug Development Fund (KDDF) and that it has …